Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Invesque Ord Shs T.IVQ

Alternate Symbol(s):  MHIVF | T.IVQ.DB.U | T.IVQ.DB.V

Invesque Inc. is a health care real estate company. The Company owns a portfolio of North American properties across the health care spectrum. The Company invests in a portfolio of predominantly privately paid senior housing communities. The Company's portfolio includes investments primarily in independent living, assisted living, and memory care, which are operated under long-term leases and joint venture arrangements with industry operating partners. The Company's portfolio also includes investments in owner-occupied seniors housing properties in which the Company owns the real estate, the licensed operations, and provides management services through Commonwealth Senior Living, LLC. It owns a portfolio of over 56 properties in the United States, comprised of 53 assisted living and memory care facilities and three skilled nursing facilities. In Canada, the Company owns an interest in four seniors housing assets.


TSX:IVQ - Post by User

Comment by Capharnaumon Oct 14, 2021 12:49pm
105 Views
Post# 34005687

RE:RE:RE:RE:RE:RE:Value of U debentures

RE:RE:RE:RE:RE:RE:Value of U debentures
Stratocheif wrote: I guess you bought them at recent market price. But many investors bought them near par years ago. So for us there us no advantage to selling or evaluating what benefit may be had from getting shares. Ive seen companies convert to shares only to see the sp drop big time after so how am i gonna get my money back having bought at par. I may be wrong about who holds these debentures but i dont see it that debenture holders were thrown under the bus. It says in the proposal that they have had input from debenture holders..major ones i assume and they feel this is the way to go. Ivq has no obligation to engage a third party to give an opinion on this...its a minor thing. If they were selling the company or acquiring another yes people want to know if it was a good decision. And there is no obligation to warn about risks as to the ability of ivq to continue as a going concern. Those warnings only come when a company is already engaged in bankrupty preapration. We arent there now...maybe coming but no indication at all at this point. Debenture holders werent thrown under the bus. They just got thier bonds extended and at a better rate and they got a partial redemption. Dont see any problem with that...unless one feels the probability of insolvency is very high. Ivq gets to keep 34 million cash that may help them sort out some of thier issues and return to a better position. Its too bad we are at this point but it could have been worse imo...100% conversion to shares would be the dilution from hell and extending at same interest rate no good either. Sure they could have redeemed 100% and then borrowed again at 8 or 9% but would that have been acceptable to shareholders? I think its a good compromise all things considered.


Well... if the deal is rejected and they announce they will pay in shares, you could sell your debentures before the conversion for a price upwards of $90 (probably around $95). If you accept the deal, you will receive $22 instead of $90-95 and then your new issue will be worth about another $50-60, up to $78 if you hold them and they don't devalue them again in three years. I don't know in what world you think this is better. I own debentures since pre-covid, but I still don't see why the value of what I hold should be devalued arbitrarily to preserve the value of the two big funds holding commons.

Plus, as I've said many times, these are CONVERTIBLE DEBENTURES and part of the value is in the conversion rate. The offer is at 200% premium... (300% of the share price) which is really outside of the range of what's acceptable. I wouldn't have a problem if the offer was 6.25% with a convertible rate of $3 USD (50% premium, 150% of the share price).

Take Chemtrade, for example, in a similar situation, who didn't screw the debentures holders... they redeemed a debenture at 5% with a conversion price of $16 and issued a new debenture at 8.5% with a conversion price of $7.35, a premium of 45% (145% of the share price at issue). Just because we hold the debentures doesn't mean we should get screwed on the extended conversion premium. The least they could have done would have been to offer a premium that's more aligned with the kind of premium you see on the market.

As to what's acceptable to shareholders... It should be market value debt or dilution or something else (selling one property), that's the risk associated with being a common shareholder. If you have a higher priority debt instrument with limited upside, why should you compensate that risk for the commons?

Considering the commons are worth $145M (CAD!) and the debentures are worth $45M USD (40% of the market cap), it is a material event and they should have provided a neutral opinion on the value of their offer.

I guess there are people that are okay being walked over.
<< Previous
Bullboard Posts
Next >>